Minimization of immunosuppression with thymoglobuline pre-treatment and HCV recurrence in liver transplantation

Clinical Transplantation

Volumn 19, Issue 2, 2005, Pages 255-258

  De Ruvo, Nicola ^a   Cucchetti, Alessandro ^a   Lauro, Augusto ^a   Masetti, Michele ^b   Di Benedetto, Fabrizio ^b   Cautero, Nicola ^b   La Barba, Giuliano ^a   Dazzi, Alessandro ^a   Di Francesco, Fabrizio ^b   Molteni, Gabriele ^b   Romano, Antonio ^b   Ramacciato, Giovanni ^a   Risaliti, Andrea ^b   Pinna, Antonio Daniele ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

HCV; Immunosuppression; Liver transplantation; Recurrence; Tolerance

Indexed keywords

METHYLPREDNISOLONE; POLYCLONAL ANTIBODY; TACROLIMUS; THYMOCYTE ANTIBODY; VIRUS RNA;

ACUTE GRAFT REJECTION; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; LOW DRUG DOSE; MALE; POSTOPERATIVE CARE; PRIORITY JOURNAL; RECURRENT INFECTION; SURVIVAL RATE; VIRUS LOAD;

ADULT; AGED; ANTILYMPHOCYTE SERUM; DNA, VIRAL; FOLLOW-UP STUDIES; GRAFT REJECTION; GRAFT SURVIVAL; HEPACIVIRUS; HEPATITIS C; HUMANS; IMMUNOSUPPRESSION; IMMUNOSUPPRESSIVE AGENTS; LIVER TRANSPLANTATION; METHYLPREDNISOLONE; MIDDLE AGED; RECURRENCE; SURVIVAL RATE; T-LYMPHOCYTES; TACROLIMUS; TRANSPLANTATION CONDITIONING; TREATMENT OUTCOME; VIRAL LOAD;

EID: 20144367590     PISSN: 09020063     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-0012.2005.00333.x     Document Type: Article

References (18)

1. Stegall MD, Everson G, Schroter G et al. Metabolic complications after liver transplantation. Diabetes, hypercholesterolemia, hypertension and obesity. Transplantation 1995: 60: 1057.
2. Singh N, Gayowski T, Ndimbie OK et al. Recurrent hepatitis c virus hepatitis in liver transplant recipients receiving tacrolimus: association with rejection and increased immunosuppression after transplantation. Surgery 1996: 119: 452.
3. Berenguer M. Host and donor risk factor before and after liver transplantation that impact HCV recurrence. Liver Transplant 2003: 9: S44
4. Gane EJ, Naoumov NV, Qian KP et al. A longitudinal analysis of hepatitis C virus replication following liver transplantation. Gastroenterology 1996: 110: 167.
5. Everson G. Impact of immunosuppressive therapy on recurrence of hepatitis C. Liver Transplant 2002: 8: 19.
6. Starzl TE, Zinkernagel RM. Transplantation tolerance from a historical perspective. Nat Rev Immunol 2001: 1: 233.
7. Starzl TE, Murase N, Abu-Elmagd K et al. Tolerogenic immunosuppression for organ transplantation. Lancet 2003: 361: 1502.
8. Shapiro R, Jordan M, Basu A et al. Kidney transplantation under a tolerogenic regimen of recipient pretreatment and low-dose postoperative immunosuppression with subsequent weaning. Ann Surg 2003: 238: 520.
9. Langrehr JM, Nussler NC, Neumann U et al. A prospective randomized trial comparing interleukin-2 receptor antibody versus anti-thymocite globulin as part of a quadruple immunosuppressive induction therapy following orthotopic liver transplantation. Transplantation 1997: 63: 1772.
10. Tchervenkov JI, Tector AJ, Cantarovich M et al. Maintenance immunosuppression using cyclosporine monotherapy in adult orthotopic liver transplant recipients. Transplant Proc 1996: 28: 2247.
11. Eason JD, Loss GE, Blazek J, Nair S, Mason AL. Steroid-free liver transplantation using rabbit antithymocite globulin and early tacrolimus monotherapy. Transplantation 2003: 75: 1396.
12. Ishak K, Baptista A, Bianchi L et al. Histological grading and staging of chronic hepatitis. J Hepatol 1995: 22: 696.
13. Tector AJ, Fridell JA, Mangus RS et al. Promising early results with immunosuppression using rabbit antithymocyte globulin and steroids with delayed introduction of tacrolimus in adult liver transplant recipients. Liver Transplant 2004: 10: 404.
14. Berenguer M, Lopez-Labrador FX, Wright TL. Hepatitis C and liver transplantation. J Hepatol 2001: 35: 666.
15. Mc Caughan G, Zekry A. Impact of immunosuppression on immunopathogenesis of liver damage in hepatitis C virus-infected recipients following liver transplantation. Liver Transplant 2003: 9: S21.
16. Garcia-Retortillo M, Forns X, Feliu A et al. Hepatitis c virus kinetics before and immediately after liver transplantation. Hepatology 2002: 35: 680.
17. Berenguer M, Prieto M, Cordoba J et al. Early development of chronic active hepatitis in recurrent hepatitis C infection after liver transplantation: association with treatment of rejection. J Hepatol 1998: 28: 756.
18. Charlton M, Seaberg E, Wiesner R et al. Predictors of patient and graft survival following liver transplantation for hepatitis C. Hepatology 1998: 28: 82.